Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 168960, 7 pages
http://dx.doi.org/10.1155/2014/168960
Research Article

Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer

1Department of Thoracic Surgery, Fudan University Shanghai Cancer Center (FUSCC), Shanghai 200032, China
2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
3Department of Radiation Oncology, Kimmel Cancer Center and Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA
4Department of Biostatistics, Public Health School, Fudan University, Shanghai 200032, China
5Department of Pathology, Fudan University Shanghai Cancer Center (FUSCC), Shanghai 200032, China
6Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, China

Received 21 September 2014; Revised 24 November 2014; Accepted 25 November 2014; Published 10 December 2014

Academic Editor: Yi-Chia Huang

Copyright © 2014 Wei Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Wei Guo, Xiao Ma, Christine Xue, et al., “Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer,” Disease Markers, vol. 2014, Article ID 168960, 7 pages, 2014. https://doi.org/10.1155/2014/168960.